GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Par Drugs and Chemicals Ltd (NSE:PAR) » Definitions » Gross Margin %

Par Drugs and Chemicals (NSE:PAR) Gross Margin % : 68.19% (As of Mar. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Par Drugs and Chemicals Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Par Drugs and Chemicals's Gross Profit for the three months ended in Mar. 2024 was ₹155.6 Mil. Par Drugs and Chemicals's Revenue for the three months ended in Mar. 2024 was ₹228.2 Mil. Therefore, Par Drugs and Chemicals's Gross Margin % for the quarter that ended in Mar. 2024 was 68.19%.


The historical rank and industry rank for Par Drugs and Chemicals's Gross Margin % or its related term are showing as below:

NSE:PAR' s Gross Margin % Range Over the Past 10 Years
Min: 24.84   Med: 31.28   Max: 64.67
Current: 64.67


During the past 8 years, the highest Gross Margin % of Par Drugs and Chemicals was 64.67%. The lowest was 24.84%. And the median was 31.28%.

NSE:PAR's Gross Margin % is ranked better than
78.76% of 984 companies
in the Drug Manufacturers industry
Industry Median: 46.755 vs NSE:PAR: 64.67

Par Drugs and Chemicals had a gross margin of 68.19% for the quarter that ended in Mar. 2024 => Durable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Par Drugs and Chemicals was 19.00% per year.


Par Drugs and Chemicals Gross Margin % Historical Data

The historical data trend for Par Drugs and Chemicals's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Par Drugs and Chemicals Gross Margin % Chart

Par Drugs and Chemicals Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Gross Margin %
Get a 7-Day Free Trial 28.08 37.48 32.80 57.88 64.67

Par Drugs and Chemicals Quarterly Data
Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 63.92 57.83 65.20 67.27 68.19

Competitive Comparison of Par Drugs and Chemicals's Gross Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Par Drugs and Chemicals's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Par Drugs and Chemicals's Gross Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Par Drugs and Chemicals's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Par Drugs and Chemicals's Gross Margin % falls into.



Par Drugs and Chemicals Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Par Drugs and Chemicals's Gross Margin for the fiscal year that ended in Mar. 2024 is calculated as

Gross Margin % (A: Mar. 2024 )=Gross Profit (A: Mar. 2024 ) / Revenue (A: Mar. 2024 )
=618.5 / 956.404
=(Revenue - Cost of Goods Sold) / Revenue
=(956.404 - 337.918) / 956.404
=64.67 %

Par Drugs and Chemicals's Gross Margin for the quarter that ended in Mar. 2024 is calculated as


Gross Margin % (Q: Mar. 2024 )=Gross Profit (Q: Mar. 2024 ) / Revenue (Q: Mar. 2024 )
=155.6 / 228.192
=(Revenue - Cost of Goods Sold) / Revenue
=(228.192 - 72.577) / 228.192
=68.19 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Par Drugs and Chemicals  (NSE:PAR) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Par Drugs and Chemicals had a gross margin of 68.19% for the quarter that ended in Mar. 2024 => Durable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Par Drugs and Chemicals Gross Margin % Related Terms

Thank you for viewing the detailed overview of Par Drugs and Chemicals's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Par Drugs and Chemicals (NSE:PAR) Business Description

Traded in Other Exchanges
N/A
Address
Gotri Vasna Road, 816, Nilamber Triumph, Vadodara, GJ, IND, 390007
Par Drugs and Chemicals Ltd is engaged in the development and manufacture of Active Pharma Ingredients (APIs) for the domestic market as well as for exports to international markets. APIs are the principal ingredient used in making finished dosages in the form of capsules, tablets, liquid, or other forms of dosage.